STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc. (SSKN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sskn · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
STRATA Skin Sciences, Inc.You SSKN | $1M | N/A | — | — |
 Adial Pharmaceuticals, Inc. ADIL | $2M | N/A | — | -$11.93 |
 Addex Therapeutics Ltd ADXN | $4M | N/A | — | -$7.20 |
 Brainstorm Cell Therapeutics Inc. BCLI | $9M | N/A | — | -$1.11 |
 Biomerica, Inc. BMRA | $6M | N/A | — | -$2.16 |
 GBS Inc. GBS | $0M | N/A | — | -$2.00 |
 HeartSciences Inc. HSCS | $4M | N/A | — | -$9.34 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for STRATA Skin Sciences, Inc. (SSKN) measures how much investors pay for each dollar of the company's trailing earnings. SSKN's current PE ratio of N/A is calculated by dividing its stock price of $0.13 by its TTM earnings per share of —.
Frequently asked questions
SSKN pe ratio · 6 questionsSSKN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.13 and TTM EPS of —. Data sourced from Financial Modeling Prep via SSKN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · STRATA Skin Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09